154 related articles for article (PubMed ID: 35072848)
21. Stevioside Attenuates Insulin Resistance in Skeletal Muscle by Facilitating IR/IRS-1/Akt/GLUT 4 Signaling Pathways: An In Vivo and In Silico Approach.
Deenadayalan A; Subramanian V; Paramasivan V; Veeraraghavan VP; Rengasamy G; Coiambatore Sadagopan J; Rajagopal P; Jayaraman S
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946771
[TBL] [Abstract][Full Text] [Related]
22. Effects of crocin and voluntary exercise, alone or combined, on heart VEGF-A and HOMA-IR of HFD/STZ induced type 2 diabetic rats.
Ghorbanzadeh V; Mohammadi M; Dariushnejad H; Chodari L; Mohaddes G
J Endocrinol Invest; 2016 Oct; 39(10):1179-86. PubMed ID: 27094045
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effects of globular adiponectin in diabetic rats with nonalcoholic fatty liver disease.
Ma H; Cui F; Dong JJ; You GP; Yang XJ; Lu HD; Huang YL
World J Gastroenterol; 2014 Oct; 20(40):14950-7. PubMed ID: 25356056
[TBL] [Abstract][Full Text] [Related]
24. Beneficial effects of combination therapy of phloretin and metformin in streptozotocin-induced diabetic rats and improved insulin sensitivity in vitro.
Shen X; Wang L; Zhou N; Gai S; Liu X; Zhang S
Food Funct; 2020 Jan; 11(1):392-403. PubMed ID: 31821397
[TBL] [Abstract][Full Text] [Related]
25. The combined effect of metformin and L-cysteine on inflammation, oxidative stress and insulin resistance in streptozotocin-induced type 2 diabetes in rats.
Salman ZK; Refaat R; Selima E; El Sarha A; Ismail MA
Eur J Pharmacol; 2013 Aug; 714(1-3):448-55. PubMed ID: 23845213
[TBL] [Abstract][Full Text] [Related]
26. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus.
Folli F; Saad MJ; Backer JM; Kahn CR
J Clin Invest; 1993 Oct; 92(4):1787-94. PubMed ID: 7691886
[TBL] [Abstract][Full Text] [Related]
27. Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome.
Borges Canha M; Portela-Cidade JP; Conceição G; Sousa-Mendes C; Leite S; Fontoura D; Moreira-Gonçalves D; Falcão-Pires I; Lourenço A; Leite-Moreira A; Pimentel-Nunes P
Rev Esp Enferm Dig; 2017 Jul; 109(7):491-497. PubMed ID: 28593786
[TBL] [Abstract][Full Text] [Related]
28. Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers.
Honma M; Sawada S; Ueno Y; Murakami K; Yamada T; Gao J; Kodama S; Izumi T; Takahashi K; Tsukita S; Uno K; Imai J; Kakazu E; Kondo Y; Mizuno K; Kawagishi N; Shimosegawa T; Katagiri H
Int J Obes (Lond); 2018 Sep; 42(9):1544-1555. PubMed ID: 29717275
[TBL] [Abstract][Full Text] [Related]
29. Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats.
Linden MA; Lopez KT; Fletcher JA; Morris EM; Meers GM; Siddique S; Laughlin MH; Sowers JR; Thyfault JP; Ibdah JA; Rector RS
Appl Physiol Nutr Metab; 2015 Oct; 40(10):1038-47. PubMed ID: 26394261
[TBL] [Abstract][Full Text] [Related]
30. Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.
Linden MA; Fletcher JA; Morris EM; Meers GM; Kearney ML; Crissey JM; Laughlin MH; Booth FW; Sowers JR; Ibdah JA; Thyfault JP; Rector RS
Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E300-10. PubMed ID: 24326426
[TBL] [Abstract][Full Text] [Related]
31. Pioglitazone normalizes insulin signaling in the diabetic rat retina through reduction in tumor necrosis factor α and suppressor of cytokine signaling 3.
Jiang Y; Thakran S; Bheemreddy R; Ye EA; He H; Walker RJ; Steinle JJ
J Biol Chem; 2014 Sep; 289(38):26395-26405. PubMed ID: 25086044
[TBL] [Abstract][Full Text] [Related]
32. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
[TBL] [Abstract][Full Text] [Related]
33. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
[TBL] [Abstract][Full Text] [Related]
34. The Short-term Effects of Insulin, Metformin and Insulin-Metformin Combination on the Liver Morphology in High Fat Diet / Streptozotocin Induced Diabetic Albino Rats.
Mubeen S; Amjad Z; Memon FM; Ashraf SU
J Coll Physicians Surg Pak; 2016 Dec; 26(12):962-966. PubMed ID: 28043307
[TBL] [Abstract][Full Text] [Related]
35. Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin.
DeFronzo RA; Triplitt C; Qu Y; Lewis MS; Maggs D; Glass LC
Diabetes Care; 2010 May; 33(5):951-7. PubMed ID: 20107105
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of different antidiabetic drugs based on metformin in the treatment of type 2 diabetes mellitus: A network meta-analysis involving eight eligible randomized-controlled trials.
Peng Y; Chen SH; Liu XN; Sun QY
J Cell Physiol; 2019 Mar; 234(3):2795-2806. PubMed ID: 30145806
[TBL] [Abstract][Full Text] [Related]
37. Effect of Shenzhu Tiaopi granule on hepatic insulin resistance in diabetic Goto-Kakizakirats via liver kinase B1/adenosine 5'-monophosphate/mammalian target of rapamycin signaling pathway.
Yin Y; Fang Z; Wu Y; You L
J Tradit Chin Med; 2021 Feb; 41(1):107-116. PubMed ID: 33522203
[TBL] [Abstract][Full Text] [Related]
38. Swertisin rich fraction from Enicostema littorale ameliorates hyperglycemia and hyperlipidemia in high-fat fed diet and low dose streptozotacin induced type 2 diabetes mellitus in rats.
Mokashi P; Bhatt LK; Khanna A; Pandita N
Biomed Pharmacother; 2017 Dec; 96():1427-1437. PubMed ID: 29031588
[TBL] [Abstract][Full Text] [Related]
39. Agriophyllum oligosaccharides ameliorate hepatic injury in type 2 diabetic db/db mice targeting INS-R/IRS-2/PI3K/AKT/PPAR-γ/Glut4 signal pathway.
Bao S; Wu YL; Wang X; Han S; Cho S; Ao W; Nan JX
J Ethnopharmacol; 2020 Jul; 257():112863. PubMed ID: 32302715
[TBL] [Abstract][Full Text] [Related]
40. [The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice].
Wang X; He H; Liang LB; Zhang M; Li SY; Li SQ; An ZM; Huang HJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):28-32. PubMed ID: 28612554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
